查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1612943

屈公病市場：按類型、最終用戶分類 - 全球預測 2025-2030

Chikungunya Market by Type (Diagnosis, Treatment), End-Users (Diagnostic Centers, Hospitals & Clinics, Research Institutions) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年屈公病市值為5.2933億美元，預計2024年將達5.6511億美元，複合年成長率為6.89%，預計到2030年將達到8.4397億美元。

屈公病是一種由蚊子傳播的病毒性疾病，由於零星爆發和相關的令人衰弱的關節疼痛，越來越被認為是一個公共衛生問題。此市場研究的範圍包括屈公病流行病學、預防、治療和管理策略，以及疫苗和治療開發的監測。需要進行全面的市場分析，因為屈公病造成的全球健康負擔，推動了對有效疫苗和抗病毒藥物的需求。應用和最終用途包括製藥、醫療機構、公共衛生政策框架和病媒控制機制。關鍵的成長要素包括意識的提高、政府對研究的資助以及蚊子控制技術的進步。由於熱帶和亞熱帶地區庫蚊活動範圍的擴大以及疾病發病率的增加，潛在的市場機會正在擴大。然而，市場開拓受到低收入地區基礎設施不足、疫苗開發複雜以及來自登革熱和瘧疾等其他蚊媒疾病的競爭的限制。

主要市場統計
基準年[2023] 52933萬美元
預計年份 [2024] 56511萬美元
預測年份 [2030] 8.4397 億美元
複合年成長率（%） 6.89%

此外，疫苗分發和公眾接受新產品方面的文化和後勤挑戰可能會阻礙市場滲透。創新和研究的機會在於開發具有成本效益且可擴展的病媒控制解決方案、推進疫苗試驗以及改善緩解症狀的治療性介入。專注於基因編輯以減少蚊子繁殖或傳播的研究可能具有變革性。此外，開發用於早期檢測和遠端醫療諮詢的行動醫療技術可以提高疾病管理的效率。屈公病市場表現出週期性需求模式，通常在流行病期間激增，並受到旅行和氣候變遷等因素的影響，這表明需要採取適應性市場策略。公司可以利用與當地衛生當局的合作夥伴關係以及對意識計劃的投資來提高產品的使用率。研發方面的策略夥伴關係可以進一步加速新穎解決方案的部署，滿足趨勢市場和新興市場的需求。

市場動態：揭示快速發展的基孔肯亞市場的關鍵市場洞察

供需的動態交互作用正在改變屈公病市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 全球基孔肯雅病毒盛行率上升
    • 支持監管機構的國際衛生法規和政策
    • 增加政府和非政府措施以提高意識
  • 市場限制因素
    • 與研發相關的高成本
  • 市場機會
    • 屈公病診斷技術與治療方案的進展
    • 整合遠端醫療服務來管理屈公病
  • 市場挑戰
    • 屈公病疫苗開發與生產的複雜性

波特的五力：駕馭屈公病市場的策略工具

波特的五力架構是了解屈公病市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解屈公病市場的外部影響

外部宏觀環境因素在塑造屈公病市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解屈公病市場的競爭狀況

對屈公病市場的詳細市場佔有率分析可以對供應商的業績進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 屈公病市場定位矩陣供應商績效評估

FPNV 定位矩陣是評估屈公病市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議繪製屈公病市場的成功之路

屈公病市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 基孔肯雅病毒全球盛行率增加
      • 支持監管機構的國際衛生法規和政策
      • 加強政府和非政府努力提高意識
    • 抑制因素
      • 研發成本高
    • 機會
      • 屈公病診斷技術與治療方案的進展
      • 透過遠端醫療服務和遠端醫療整合管理屈公病
    • 任務
      • 屈公病疫苗開發與生產的複雜性
  • 市場區隔分析
    • 類型：加強屈公病下一代治療方法的研發
    • 最終用戶：酷拉布
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 基孔肯雅市場：依類型

  • 診斷
    • 血清學檢測
    • 病毒檢測測試
  • 治療

第 7 章 基孔肯雅市場：依最終用戶分類

  • 診斷中心
  • 醫院/診所
  • 調查機構

第8章美洲屈公病市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章 亞太地區屈公病市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章 歐洲、中東和非洲的屈公病市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • FDA核准Ixchiq：針對高危險成人的屈公病新疫苗
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company（BD）
  • BioMedomics Inc.
  • Cellex, Inc.
  • Chembio Diagnostic Systems, Inc. by Biosynex
  • Creative Diagnostics
  • ELITechGroup by Bruker Corporation
  • Eurofins Scientific Ltd.
  • F. Hoffmann La-Roche Ltd
  • Grifols Diagnostic Solutions Inc.
  • Immucor, Inc.
  • Quest Diagnostics
  • Randox Laboratories Ltd.
  • Serological Research Institutes
  • Thermo Fisher Scientific, Inc.
Product Code: MRR-CD5A9334D93F

The Chikungunya Market was valued at USD 529.33 million in 2023, expected to reach USD 565.11 million in 2024, and is projected to grow at a CAGR of 6.89%, to USD 843.97 million by 2030.

Chikungunya, a mosquito-borne viral disease, has been increasingly recognized as a public health concern due to sporadic outbreaks and its associated debilitating joint pain. The scope of this market research encompasses the epidemiology, prevention, treatment, and management strategies for chikungunya, alongside monitoring vaccine and therapeutic developments. The necessity for comprehensive market analysis lies in the global health burden posed by chikungunya, driving demand for effective vaccines and anti-viral drugs. Application and end-use span across pharmaceuticals, healthcare institutions, public health policy frameworks, and vector control mechanisms. Key growth influencers include rising awareness, government funding for research, and technological advancements in mosquito control. The potential market opportunity is magnified by the expanding geographic range of Aedes mosquitoes and increasing incidences of disease outbreaks in tropical and subtropical regions. However, market growth faces limitations such as insufficient infrastructure in low-income regions, the complexities of vaccine development, and competition with other mosquito-borne disease priorities like dengue and malaria.

KEY MARKET STATISTICS
Base Year [2023] USD 529.33 million
Estimated Year [2024] USD 565.11 million
Forecast Year [2030] USD 843.97 million
CAGR (%) 6.89%

Moreover, cultural and logistical challenges in vaccine distribution and public acceptance of new products may hinder market penetration. Opportunities for innovation and research lie in developing cost-effective and scalable vector control solutions, advancing vaccine trials, and improving therapeutic interventions to alleviate symptoms. Research focusing on genetic editing to reduce mosquito fertility or transmissibility could be transformative. Furthermore, creating mobile health technologies for early detection and telemedicine consultations can augment disease management efficiency. The chikungunya market exhibits cyclic demand patterns, often spiking during outbreaks, and is influenced by factors like travel and climate change, suggesting a need for adaptive market strategies. Businesses can capitalize on collaborations with local health authorities and investing in awareness programs to enhance product uptake. Strategic partnerships in research and development can further accelerate novel solution rollouts, catering to both endemic and emergent markets.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Chikungunya Market

The Chikungunya Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increased prevalence of chikungunya virus globally
    • Supportive international health regulations and policies by regulatory bodies
    • Increasing government and non-government initiatives to raise awareness
  • Market Restraints
    • High costs associated with research and development
  • Market Opportunities
    • Advancements in diagnostic techniques and treatment options for Chikungunya
    • Integration of telemedicine services for remote care to manage Chikungunya
  • Market Challenges
    • Complexities in vaccine development and manufacturing for Chikungunya

Porter's Five Forces: A Strategic Tool for Navigating the Chikungunya Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Chikungunya Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Chikungunya Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Chikungunya Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Chikungunya Market

A detailed market share analysis in the Chikungunya Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Chikungunya Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Chikungunya Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Chikungunya Market

A strategic analysis of the Chikungunya Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Chikungunya Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Beckman Coulter, Inc., Becton, Dickinson and Company (BD), BioMedomics Inc., Cellex, Inc., Chembio Diagnostic Systems, Inc. by Biosynex, Creative Diagnostics, ELITechGroup by Bruker Corporation, Eurofins Scientific Ltd., F. Hoffmann La-Roche Ltd, Grifols Diagnostic Solutions Inc., Immucor, Inc., Quest Diagnostics, Randox Laboratories Ltd., Serological Research Institutes, and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the Chikungunya Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Diagnosis and Treatment. The Diagnosis is further studied across Serological Tests and Viral Detection Tests.
  • Based on End-Users, market is studied across Diagnostic Centers, Hospitals & Clinics, and Research Institutions.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increased prevalence of chikungunya virus globally
      • 5.1.1.2. Supportive international health regulations and policies by regulatory bodies
      • 5.1.1.3. Increasing government and non-government initiatives to raise awareness
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with research and development
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in diagnostic techniques and treatment options for Chikungunya
      • 5.1.3.2. Integration of telemedicine services for remote care to manage Chikungunya
    • 5.1.4. Challenges
      • 5.1.4.1. Complexities in vaccine development and manufacturing for Chikungunya
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Rising R&D toward development of next generation treatment for chikungunya
    • 5.2.2. End-Users: Coolab
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Chikungunya Market, by Type

  • 6.1. Introduction
  • 6.2. Diagnosis
    • 6.2.1. Serological Tests
    • 6.2.2. Viral Detection Tests
  • 6.3. Treatment

7. Chikungunya Market, by End-Users

  • 7.1. Introduction
  • 7.2. Diagnostic Centers
  • 7.3. Hospitals & Clinics
  • 7.4. Research Institutions

8. Americas Chikungunya Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Chikungunya Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Chikungunya Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
    • 11.3.1. FDA Approval of Ixchiq: A New Vaccine Against Chikungunya for High-Risk Adults
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Beckman Coulter, Inc.
  • 3. Becton, Dickinson and Company (BD)
  • 4. BioMedomics Inc.
  • 5. Cellex, Inc.
  • 6. Chembio Diagnostic Systems, Inc. by Biosynex
  • 7. Creative Diagnostics
  • 8. ELITechGroup by Bruker Corporation
  • 9. Eurofins Scientific Ltd.
  • 10. F. Hoffmann La-Roche Ltd
  • 11. Grifols Diagnostic Solutions Inc.
  • 12. Immucor, Inc.
  • 13. Quest Diagnostics
  • 14. Randox Laboratories Ltd.
  • 15. Serological Research Institutes
  • 16. Thermo Fisher Scientific, Inc.

LIST OF FIGURES

  • FIGURE 1. CHIKUNGUNYA MARKET RESEARCH PROCESS
  • FIGURE 2. CHIKUNGUNYA MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CHIKUNGUNYA MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CHIKUNGUNYA MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CHIKUNGUNYA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CHIKUNGUNYA MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CHIKUNGUNYA MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS CHIKUNGUNYA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS CHIKUNGUNYA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES CHIKUNGUNYA MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES CHIKUNGUNYA MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC CHIKUNGUNYA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC CHIKUNGUNYA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA CHIKUNGUNYA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CHIKUNGUNYA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. CHIKUNGUNYA MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. CHIKUNGUNYA MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CHIKUNGUNYA MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CHIKUNGUNYA MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CHIKUNGUNYA MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CHIKUNGUNYA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CHIKUNGUNYA MARKET DYNAMICS
  • TABLE 7. GLOBAL CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CHIKUNGUNYA MARKET SIZE, BY SEROLOGICAL TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CHIKUNGUNYA MARKET SIZE, BY VIRAL DETECTION TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CHIKUNGUNYA MARKET SIZE, BY TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CHIKUNGUNYA MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CHIKUNGUNYA MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CHIKUNGUNYA MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS CHIKUNGUNYA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES CHIKUNGUNYA MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC CHIKUNGUNYA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 41. AUSTRALIA CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 44. CHINA CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 47. INDIA CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 50. INDONESIA CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 53. JAPAN CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 56. MALAYSIA CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 59. PHILIPPINES CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 62. SINGAPORE CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 65. SOUTH KOREA CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 68. TAIWAN CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 71. THAILAND CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 74. VIETNAM CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA CHIKUNGUNYA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 81. DENMARK CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 84. EGYPT CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 87. FINLAND CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 90. FRANCE CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 93. GERMANY CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 96. ISRAEL CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 99. ITALY CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 102. NETHERLANDS CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 105. NIGERIA CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 108. NORWAY CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 111. POLAND CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 114. QATAR CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 117. RUSSIA CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 120. SAUDI ARABIA CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH AFRICA CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 126. SPAIN CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 129. SWEDEN CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 132. SWITZERLAND CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 135. TURKEY CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED ARAB EMIRATES CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED KINGDOM CHIKUNGUNYA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM CHIKUNGUNYA MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM CHIKUNGUNYA MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 144. CHIKUNGUNYA MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 145. CHIKUNGUNYA MARKET, FPNV POSITIONING MATRIX, 2023